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Abstract
Background: Rates of chronic pain are rising sharply in the United States and worldwide. Presently, there is
evidence of racial disparities in pain treatment and treatment outcomes in the United States but few interventions
designed to address these disparities. There is growing consensus that chronic musculoskeletal pain is best
addressed by a biopsychosocial approach that acknowledges the role of psychological and environmental factors,
some of which differ by race.
Methods/Design: The primary aim of this randomized controlled trial is to test the effectiveness of a non-
pharmacological, self-regulatory intervention, administered proactively by telephone, at improving pain outcomes
and increasing walking among African American patients with hip, back and knee pain. Participants assigned to
the intervention will receive a telephone counselor delivered pedometer-mediated walking intervention that
incorporates action planning and motivational interviewing. The intervention will consist of 6 telephone counseling
sessions over an 8–10 week period. Participants randomly assigned to Usual Care will receive an informational
brochure and a pedometer. The primary outcome is chronic pain-related physical functioning, assessed at
6 months, by the revised Roland and Morris Disability Questionnaire, a measure recommended by the Initiative
on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT). We will also examine whether the
intervention improves other IMMPACT-recommended domains (pain intensity, emotional functioning, and ratings of
overall improvement). Secondary objectives include examining whether the intervention reduces health care service
utilization and use of opioid analgesics and whether key contributors to racial/ethnic disparities targeted by the
intervention mediate improvement in chronic pain outcomes Measures will be assessed by mail and phone surveys
at baseline, three months, and six months. Data analysis of primary aims will follow intent-to-treat methodology.
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Discussion: We will tailor our intervention to address key contributors to racial pain disparities and examine the
effects of the intervention on important pain treatment outcomes for African Americans with chronic
musculoskeletal pain.
Trial registration: ClinicalTrials.gov: NCT01983228. Registered 6 November 2013.
Keywords: Chronic musculoskeletal pain, African American, Veterans administration, Randomized control trial
Background
Approximately 100 million adults in the United States
(US) suffer from chronic pain, and musculoskeletal pain
is the most common type of chronic pain [1]. Moreover,
rates of chronic pain has been rising in the US, and are
expected to continue to rise [1]. This is particularly wor-
risome because chronic pain is associated with poorer
self-reported health status, worse mental health, lower
levels of employment, and higher use of medical services
[1]. Indeed, the Institute of Medicine estimates the an-
nual cost of chronic pain to be $560 to $635 billion, due
to direct cost of medical care, lost productivity, costs as-
sociated with disability programs and the burden chronic
pain places on families [1].
Presently, there is evidence of racial and ethnic dispar-
ities in pain in the United States but few interventions
designed to address these disparities [1–3]. We consider
racial/ethnic disparities in pain to be a type of health
disparity, defined as a difference in health status that
systematically and negatively impacts racial/ethnic mi-
nority groups [4]. We define racial disparities in pain
treatment, using the definition of health care disparities
from the Institute of Medicine report, Unequal Treat-
ment, as “differences in the quality of health care that
are not due to access-related factors or clinical needs,
preferences or appropriateness of intervention” [5]. Im-
portantly, contributors to racial disparities in pain are
complex and multi-level, including but not limited to ra-
cial disparities in pain treatment. We focus on African
American/white disparities in pain, although there are
also differences found for other racial/ethnic minority
groups [1].
A number of contributors to racial disparities in pain
occur at the level of the healthcare system. African
American patients in the United States are more likely
to experience barriers to accessing and utilizing health-
care. African American patients are more likely than
whites to have unmet medical needs due to myriad fac-
tors, including lack of insurance and underinsurance [6],
experiences of discrimination within and outside the
healthcare system (associated with avoiding and delaying
care), poorly coordinated care, lack of a primary care
provider, and logistical barriers (e.g., lack of childcare
and transportation) [6, 7]. African American patients
also experience racial disparities in pain treatment. They
are more likely than whites to have their pain discounted
and underestimated, are less likely to be screened for pain,
and more likely to be undertreated and to receive less or
no analgesia [1, 8–10]. African American patients also are
more likely to experience poor quality communication
with their providers, which adversely affects the quality of
pain treatment [1, 11].
Environmental factors may also contribute to racial dis-
parities in pain, through multiple pathways. There is
growing evidence that experiences of racial discrimination,
experienced within and outside healthcare, are associated
with greater pain, although the mechanisms by which this
occurs are not fully understood [12–18]. African Ameri-
cans are more likely to experience barriers that impede ef-
fective self-management, such as exercise. For example, in
the United States, African Americans are more likely to
reside in neighborhoods low in “walkability” [19, 20].
Psychological factors may also contribute to disparities
in pain, by reducing the use of effective self-management
strategies [8–10]. This includes patient beliefs and atti-
tudes that contribute to poor pain outcomes (e.g., pain-
related fear of movement, low perceived control over pain,
lower self-efficacy in coping with pain), which African
Americans are more likely to hold [1, 21, 22].
There is growing consensus that chronic musculoskel-
etal pain is best addressed by a biopsychosocial approach
that acknowledges the role of psychological and environ-
mental contributors to pain [23–28], some of which differ
for African Americans and hence contribute to disparities.
Our goal is to test an intervention to improve pain out-
comes among African American patients. This interven-
tion could be targeted to African American patients (e.g.,
to healthcare systems that predominantly serve African
American patients), as a way of reducing disparities. How-
ever, the intervention itself is not designed to test whether
it reduces disparities since we also expect the intervention
to benefit non-African Americans.
Conceptual framework
Rationale for the intervention
The intervention was based on several lines of research
evidence. First, physical activity can reduce chronic
musculoskeletal pain and improve function [16–18].
Second, proactive telephone outreach (in which a
counselor reaches out to patients to offer them the
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intervention, rather than requiring the patients to seek
out care) can address environmental barriers that lead
to lower levels of utilization of care among African
Americans [19]. Third, pedometer-based walking pro-
grams are effective at increasing walking for various
groups [20, 21], including African Americans [22–25].
Fourth, making an action plan (specifying when, where,
and how the behavior will be performed) increases the
likelihood that individuals will perform intended behav-
iors and overcome psychological and environmental
barriers [24, 25]. Fifth, motivational interviewing may
be an effective intervention strategies for improving pain
self-management and reducing pain, by intervening on
psychological contributors, which are more prevalent
among African American patients experiencing pain [26].
Finally, there is evidence that African American patients
desire non-pharmacological approaches to pain treatment,
including exercise [27].
Given the psychological and environmental contribu-
tors to racial disparities in chronic pain treatment, we
developed an intervention that addresses the multiple
contributors to chronic pain that disproportionately
affect African American patients (see Fig. 1 for a de-
piction of our hypothesized contributors to racial dis-
parities in pain). The intervention is based on a
biopsychosocial model and has several components.
Action planning and MI approaches are used to over-
come psychological barriers to exercise (low self-
efficacy for exercise and coping with pain, pain-related
fear) and promote change [28–31]. Self-efficacy is par-
ticularly important to include since a recent review
identified self-efficacy as the strongest predictor of inten-
tions to walk more [28]. Pedometers are used as a tool to
promote walking through feedback, goal setting, and
monitoring [20, 21]. Counselors will use a variety of
methods to improve coping skills (i.e., problem-solving,
counseling, planning to overcome barriers) [3], facilitate
supportive planning (i.e., making plans to increase and
strengthen helpful factors) [32], and shared planning
that involve friends and family members [19]. Although
the proposed intervention was designed to address con-
tributors to pain that African American patients are es-
pecially likely to experience, we also expected expect
that non African American patients in our veteran pop-
ulations will also experience these contributors, albeit
to a lesser extent. For example, non-African American
patients with musculoskeletal pain also experience frus-
tration with their treatment of pain within the current
healthcare system and report feeling stigmatized by
their providers [1]. Veterans are also considered to be a
vulnerable group that is at greater risk for pain and
poor pain treatment compared to non-Veterans [1].
Hence, while this intervention may be more effective
for African American patients, it should also benefit
non-African American patients in the Veterans Affairs
Healthcare System. For this reason, we believed it was
valuable to test this intervention on non-African
American Veterans. Although we do not have statistical
power to test whether this intervention reduces racial
disparities in pain, we planned to explore whether the
intervention appears to reduce racial disparities in pain
outcomes. If this intervention is effective, we can exam-
ine whether it reduces disparities in a future study that
would be powered to test this as a primary outcome,
using data from this study to inform our sample size
calculations.
Intervention 
i. Proactive Telephone 
Outreach
Outreach materials and 
outreach calls using 
counselors trained in 
Motivational 
Interviewing (MI)
ii. Counseling Intervention
Action Planning
MI Approaches
Pedometer program
Psychological Mediators 
(exercise self-efficacy, 
pain management self-
efficacy, pain-related fear 
avoidance)
Chronic Pain 
Outcomes
Primary chronic pain 
outcome: Pain-
specific physical 
functioning
Secondary chronic 
pain outcomes (pain 
intensity, emotional 
functioning, perceived 
overall improvement) 
Physical activity
Walking (steps/day)
Environ-
mental Factors 
(social support, 
relationship 
stressors, 
neighborhood 
walkability, 
household 
composition)
Sociodemographic and health-related factors (use 
of walking aid, BMI, education level, income, 
employment status, disability status)
Healthcare 
Utilization and 
Provider Factors 
(perceived 
discrimination in 
healthcare, 
experiences of care, 
utilization and 
satisfaction with pain 
treatment)
Fig. 1 Conceptual Model
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Key intervention components
Intervention condition
Mailed recruitment materials Participants assigned to
the intervention group will receive personalized engage-
ment materials, including a letter and brochure describing
the program and the benefits of walking to help manage
pain. Materials include targeted messages to enhance per-
suasive appeal among this population and were developed
using 4 focus groups among African American patients at
the Atlanta VA Medical Center (VAMC). This approach
to developing engagement materials was successfully used
by Fu and colleagues in a prior study with Veterans [25].
Telephone sessions Intervention participants will be
asked to complete six telephone counseling sessions over
a 10 week period (with a 12 week absolute cut off time
point) using a patient workbook (adapted from French
et al.) [15, 16] with visual aids and worksheets they
complete during the counseling sessions. For example,
one visual aid is a figure that describes a cycle of pain
leading to inactivity which may contribute to decondi-
tioning, and in turn, can contribute to more pain when
being active. An example of a worksheet is a table di-
vided by day in which to write number of steps, details
of walks, time spent walking, and successes and/or chal-
lenges. Participants are expected to receive approxi-
mately 180 min of total counselor time during the study.
The action planning component of this intervention was
based on a protocol and structured curriculum devel-
oped by French and colleagues. This program was found
to be effective at increasing walking in several trials in a
non-clinical population (healthy volunteers) [28–30]. It
also incorporates techniques developed in an interven-
tion that used action planning to promote physical activ-
ity among patients with chronic low back pain [18].
Participants were coached to create and write action
plans for their proposed walking activity, during the
week(s) between counseling sessions, using a template
contained in their workbooks (which prompted them to
indicate when, where, and with whom they would walk).
In order to adapt this component to our target popula-
tion, counselors are trained to coach patients in develop-
ing plans to overcome common environmental barriers
to walking experienced by members of racial minority
groups (e.g., neighborhoods that lack walking paths,
poor access to parks, lack of time) [4, 24, 25, 33]. We
specifically address fear of movement and promote self-
efficacy for walking during the action planning process
by incorporating these topics and MI approaches into
the action planning portion of the sessions.
The pedometer component of this intervention was
based on the work of French and colleagues [16], and
Krein and colleagues [21], which use modest goals to
assist participants with gradually increasing their step
counts [16, 21]. For the duration of the counseling period,
intervention participants will be asked to wear their ped-
ometer and maintain a weekly pedometer diary, which is a
protocol demonstrated to be feasible in the “Fit for Life”
[22] and H.U.B. City Steps studies [29]. The structure and
intensity of our intervention is based on prior interven-
tions that successfully increased walking and improved
pain outcomes [14, 15, 30, 34]. We particularly chose to
balance practical concerns about future dissemination,
while accommodating our intervention components and
providing a sufficient dose of counselor time.
Counselor training Counselors have at least a Master’s
degree in a counseling-related field (e.g., counseling
psychology, clinical social work) and receive at least 15 h
of training by an expert to prepare them to deliver the
intervention using a structured training manual. Train-
ing involves reviewing the treatment manual, role play-
ing, attending a Motivational Interviewing course and
review of audio-taped sessions with feedback. Session
tapes are reviewed to assess fidelity to the protocol and
to provide feedback to counselors. Counselors will partici-
pate in case consultation throughout the course of the
intervention to prevent “drift” from the manualized treat-
ment. An expert in counselor training will meet with the
study counselors about every week to provide corrective
feedback and ongoing support. In order to ensure treat-
ment integrity, all treatment sessions will be audiotaped
and 10% will be randomly selected and reviewed by trained
coders to assess both the use of treatment concordant strat-
egies and the absence of commonly used treatment strat-
egies not included in the manualized treatment.
Usual care control condition
Participants randomized to the Usual Care (UC) control
condition will receive pedometers and an informational
brochure about the benefits of walking. They will be
instructed (via a mailed postcard and reminder phone
calls) to wear the pedometer and to record their pedom-
eter readings on logs over 7 days at the baseline assess-
ment, three months and six months follow-up time
points. They will report these step counts during the
surveys, a procedure which has been used successfully in
previous studies with similar populations [8] (Burgess
2012, unpublished data). Although the pedometer is an
enhancement beyond what is received in Usual Care, we
decided to provide pedometers to participants assigned
to the control condition in order to determine whether
the intervention increases walking (as self-reported mea-
sures have not been shown to be reliable). In addition,
past studies suggest that pedometers in isolation are un-
likely to result in a sustained increase in walking among
generally sedentary individuals [20], and the use of
Bhimani et al. BMC Musculoskeletal Disorders  (2017) 18:15 Page 4 of 14
pedometer self-monitoring in research does not lead to
increased physical activity [24].
Prior studies that address acceptability, feasibility, and
potency of key components of intervention
Our research team has conducted several studies that
address acceptability, feasibility, and potency of key
components of intervention. The “Self-Management of
OsteoArthritis in Veterans” (SeMOA) study [35] was a
self-management intervention that utilized Proactive Tele-
phone Outreach and Telephone-Based Self-Management
to improve pain outcomes for non-white (mostly black)
and white VA patients with hip and knee OA. This popu-
lation of black VA patients with OA is similar to our
target population (black VA patients with MSK pain). The
intervention consisted of 12 monthly phone calls by a
health educator, who reviewed education materials and
provided support for developing individualized goals
and Action Plans related to OA management. Results
of SeMOA demonstrated the feasibility of conducting a
telephone-based self-management trial to reduce pain
among black Veterans, using a proactive recruitment
strategy based on identifying patients from the elec-
tronic medical record, and following up with a tele-
phone screener. The study met its recruitment goals
and completion rates among non-white (mostly black)
OA Veteran patients were high (89%) and comparable
to rates among whites (91%). Process evaluation of
SeMOA demonstrated that black Veterans perceived
the intervention to be helpful for improving their OA
symptoms and were more likely than whites to view it
as helpful [8]. The SeMOA intervention led to a clinically
relevant improvement in pain among black Veterans with
OA; at 12 months, the mean Arthritis Impact Measure-
ment Scales-2 (AIMS-2) pain score (measuring pain,
affect, and physical function) in the osteoarthritis self-
management group was 0.4 point lower (P = 0.105) than
in the UC group and 0.6 point lower (P = 0.007) than in
the health education (HE) group. The mean visual analog
scale pain score in the intervention group was 1.1 points
lower (P < 0.001) than in the UC group and 1.0 point
lower (CI, −1.5 to −0.5 point; P < 0.001) than in the HE
group [9, 10].
The “Tailoring Coping Skills Training (CST) for African
Americans with Osteoarthritis” pilot study involved focus
groups and a pilot trial to 1) assess the cultural appropri-
ateness of an intervention using specific CBT techniques
to improve coping skills and improve pain outcomes
among black veterans with OA, 2) tailor the intervention
and modify it for telephone, and 3) perform a pilot trial of
the intervention. These CBT techniques are part of the
proposed intervention (e.g., cognitive restructuring, relax-
ation, imagery, activity pacing). Focus groups showed that
black Veterans viewed the intervention as culturally
appropriate. Tailoring involved lowering literacy levels of
patient materials. The pilot trial of CST demonstrated
individual improvements on the AIMS-2 (among a racially
mixed sample of Veterans with OA).
Pedometer-Mediated Walking program to reduce
pain among chronic musculoskeletal pain patients. In
the “Veterans Walk to Beat Back Pain” study, 229 Vet-
erans with back pain were randomly assigned to a
pedometer-mediated walking intervention, adminis-
tered over the internet, or Usual Care (which included
general back pain education and a pedometer). Poten-
tially eligible participants were identified both through
provider referrals and by using VA electronic medical rec-
ord data. Findings from this study showed that > 90% of
patients in both groups completed 6-month assessments,
with intervention patients reporting significantly less back
pain-related disability compared to controls (Roland Mor-
ris Disability Scores: 7.2 vs. 9.2, P = 0.01) as well as lower
pain scores (4.7 vs. 5.2, P = 0.06), and greater average step
counts [36]. This project demonstrates the feasibility and
acceptability of conducting a trial of a pedometer-
mediated intervention for chronic pain patients, and
speaks to the potency of this intervention in reducing pain
related disability as well as pain levels. However, this study
was conducted on a primarily non-minority population
(who were required to have a home computer with inter-
net access), and was not designed to address barriers faced
by minority VA patients, which the present study is de-
signed to address.
Cognitive Behavioral Therapy (CBT) techniques and ex-
ercise for chronic MSK pain. Dr. Heapy and Dr. Robert
Kerns have reported a number of studies that demon-
strate the feasibility and acceptability of conducting
CBT trials with Veterans with chronic pain (including
the use of CBT to promote physical activity), as well as
formative research that provided information about the
types of coping skills most preferred by patients with
chronic pain (which included exercise). These studies
include: 1) an evaluation of the effect of a tailored
cognitive-behavioral approach to the management of
chronic back pain on promoting adherence to therapist
recommendations for pain coping skill practice; 2) a
randomized controlled trial of cognitive-behavior ther-
apy for painful diabetic peripheral neuropathic pain;
and 3) a study testing the efficacy of interactive voice
response, for delivering CBT for chronic low back pain
[37–40].
Methods/Design
The goal of this randomized controlled trial is to investi-
gate the effectiveness of the intervention in improving
the pain-related function of African American patients
with chronic musculoskeletal pain through a proactive
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coaching program designed to increase walking. Data
collection will occur at baseline (randomization) and at
three and six months post-randomization.
The specific study aims are:
Primary Aims: To test the hypothesis that compared to
UC, a proactively delivered walking intervention targeted
to African American VA patients with chronic musculo-
skeletal pain will:
(1)improve pain-related physical functioning (primary
outcome),
(2)improve emotional functioning, pain intensity, and
ratings of overall improvement (first secondary
outcome)
(3)increase walking as measured by step counts (second
secondary outcome).
Secondary Aims are to:
(1)investigate whether key contributors to racial
disparities targeted by the intervention mediate
improvement in chronic pain outcomes and
increases in walking,
(2)test the effectiveness of the intervention on non-
African American patients and explore whether ef-
fectiveness differs between African American and
non-African American patients, and
(3)examine whether the intervention reduces the use of
opioid analgesics.
This study is approved by the Institutional Review
Boards (IRBs) at the Minneapolis VAMC and VA Central
Office IRB in Washington, DC. ACTION is also reviewed
and approved annually by the granting institution, the VA
Health Services Research & Development (HSR&D)
Service.
Eligibility
Sample and eligibility criteria
Study participants will be recruited from the Atlanta
VAMC, which we chose because it has a high percentage
of African American patients. The main facility and sat-
ellite clinics have about 9,294 patients who meet our ini-
tial eligibility criteria. These criteria include having 1
hip, back or knee diagnosis code in the past year, a sec-
ond hip, back or knee diagnosis code 18 months from
the first one, and the Atlanta VA is identified as their
preferred care location. From this cohort, we will ran-
domly select patients (African Americans and non-
African Americans) for recruitment. We will include
non-African Americans in our sample for comparison
purpose. Administrative race data will be verified on
the brief screening survey.
Recruitment will be conducted via an introductory
letter, which describes the study for potential participants
and provides an option to opt out if they are not inter-
ested in participating in the study. Further, qualifying cri-
teria will be determined through the administration of a
telephone screening questionnaire. Eligible patients must
have pain duration of ≥ 6 months, moderate-severe pain
severity and interference with function (defined as a brief
pain intensity and interference (PEG) score of ≥ 5), self-
reported ability to walk at least 1 block, and be able to
communicate effectively by telephone. The PEG (Pain in-
tensity, Enjoyment of life, General activity) is an ultra-brief
(three items) assessment tool for pain, which is valid, reli-
able and responsive to change [41–44]. The PEG is calcu-
lated using an average of the three items, each of which is
measured on scale of 0–10. Scores of ≥ 5 indicates mod-
erate to severe pain. We will not exclude patients who
are prescribed medication or receiving other treatments
for chronic pain. Patients who meet any of the follow-
ing exclusion criteria that may interfere with the out-
come assessment are ineligible: a) moderately severe
cognitive impairment defined as ≥ 2 errors on a brief
cognitive screener (the six-item Callahan screener that
identifies cognitive impairment for potential research
subjects) [12, 38] or b) anticipated back, knee, hip or
other major surgery within the next 12 months. Be-
cause this study is considered minimal risk, we received
a waiver of signed, written consent from the IRB. In
lieu of a written consent form, participants receive an
information sheet that will be reviewed orally over the
phone by a research assistant and oral consent to par-
ticipate is required. Eligible respondents who consent
will be mailed a pedometer and a baseline survey to
complete and mail back. When completed baseline sur-
veys are received, participants will be randomized to
the UC or intervention condition.
Recruitment and telephone counseling will be con-
ducted by staff at the Center for Chronic Disease Out-
comes Research (CCDOR) at the Minneapolis VAMC.
Telephone counseling will be conducted separately
from recruitment by separate staff.
Randomization
The primary analyses will use the sample of African
American patients, and the study was intentionally de-
signed to be adequately powered to detect effects in this
core group. Additional analyses will be conducted in the
non-African American sample and the overall sample.
Because our primary aims focus on the sample of African
American patients, the methods outlined ensure the study
is sufficiently powered for this sample (see Fig. 2).
Based on our previous experience conducting inter-
ventions with African American veteran patients with
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chronic pain [13], we anticipate that we will be able to
contact greater than 50% African American patients
and that 60% will be eligible for and consent to partici-
pate in our baseline phone survey. We will recruit a
total of 500 participants in this study with a minimum
of 250 African American participants (about 125 in
intervention group and about 125 in UC group) to en-
sure adequate power for the study. Among those ran-
domized, we estimate (based on previous research
conducted [12]) that 10–15% will be missing complete
follow-up data. However, if the response rate is lower
than expected, we will increase the necessary number
of patients to enroll each month in order to accomplish
our goals for available outcome data.
Participants will be randomized to either study inter-
vention or UC (1:1) at the time that the baseline surveys
are listed as complete in the study tracking application.
At receipt of a completed baseline, participants will be
randomized and sent letters describing whether they are
in the intervention or UC group. The randomization list
will be concealed from the research team within the
tracking application, so team members will not know
the next study assignment. In order to ensure that treat-
ment is equally balanced on race the randomization is
stratified on participant self-identified African American
or non-African American status and balance in assignment
over time is achieved using permuted block randomization
with block sizes of 4, 6 or 8.
Fig. 2 Study recruitment, enrollment, intervention, assessment, and analysis flow diagram
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Screening and measures
Description of measures and data collection procedures
Data collection will be conducted by mail at baseline, and
a combination of mail and telephone at three and six
months post-randomization. At pre-screen, potential
participants will receive a pre-notice letter. About a week
later, research staff will call to assess patients’ interest, an-
swer questions, conduct an eligibility screener, go over the
information sheet (in place of an informed consent form),
and obtain oral consent. Participants will then be mailed a
baseline survey and pedometer.
Fourteen days prior to the three and six month follow-
up dates, all participants will be mailed a postcard remind-
ing them to wear their pedometers in preparation for
filling in the 7 day walking journal on the upcoming
survey. A week prior to the three and six month dates,
follow-up surveys will be mailed to all participants. Over
the course of two weeks after surveys are mailed, non-
responders will be called to ensure receipt of the survey,
answer questions, and do the survey over the phone
(instead of the mailed version) if the participant is willing.
After 3 completed reminder calls, non-responders will be
mailed another postcard reminding them to return the
paper survey. In addition, at 6 months non-responders
will receive a second copy of the survey in the mail along
with an especially engaging cover letter. (See Tables 1 and
2 for survey measures.)
Primary and secondary chronic pain outcomes We
will assess the following core chronic pain outcome do-
mains and measures recommended by IMMPACT: [45] 1)
The primary outcome of a pain-specific measure of func-
tioning will be assessed at six months using the revised
version of the Roland and Morris Disability Questionnaire
(RMD), which is widely used in studies of chronic muscu-
loskeletal pain and included in the IMMPACT recom-
mendations. The RMD at three months will also be
assessed as a secondary outcome. Although the original
version of the RMD focused on low back pain [46], the re-
vised version has been adapted for musculoskeletal pain
more broadly, and has been validated with musculoskel-
etal patients [47]. The scale has good internal consistency,
discriminative validity and is sensitive to change [48]. 2)
Emotional functioning will be assessed by the Personal
Health Questionnaire Depression Scale (PHQ-8), without
the suicidality item (7 items) [49] and the Generalized
Anxiety Disorder 7-item (GAD-7) scale [50]. 3) Pain
intensity will be assessed by the 3-item PEG [41, 42]. 4)
Participant rating of overall improvement will be assessed
at three and six months by the Patient Global Impression
of Change scale, a single item measure assessing patients’
views of improvement/worsening of their pain [4].
Walking Walking will be measured as the number of
average daily steps using pedometer readings recorded
in walking logs at three and six months, based on seven
consecutive days of data. We are using the Omron HJ-
321 pedometer, which can be worn in a pocket, around
the neck, or on a belt clip (orientation does not matter)
and has been shown to be highly accurate, including in
obese populations [33]. Patients will be provided with
written instructions on how to use the pedometers. The
instructions were assessed as part of the Atlanta focus
groups and revised to be better understood by our par-
ticipant population. Participants in the intervention arm
will have additional support for ongoing pedometer use
as part of the intervention, but the walking outcome as-
sessment protocol is identical in both arms.
Psychological factors (mediators) Pain-related fear
avoidance will be measured by the fear-avoidance beliefs
about physical activity subscale (Scale 1) of the Fear-
Avoidance Beliefs Questionnaire (FABQ) [51]. Self-efficacy
for exercise will be measured using the Exercise Regularly
Scale, which includes questions asking respondents how
confident they are they can do aerobic exercise such as
walking three to four times each week, and how confident
they are that they can exercise without making symptoms
worse. Pain management self-efficacy will be measured
using the eight item Pain Self-Efficacy Questionnaire
(PSEQ-8) [36], which has been used in numerous studies
with chronic pain patients.
Environmental factors Social support for exercise will
be assessed using the Marcus Social Support questions
[52], and relationship stressors by the Life Stressors In-
ventory (LISRES-A) [53]. We will assess neighborhood
walkability using the Neighborhood Environment Walkabil-
ity Scale (NEWS) [54]. As part of the general demographic
questions at baseline, we will also ask a question to assess
household composition.
Healthcare utilization and provider factors These fac-
tors will include perceived discrimination in healthcare
Table 1 Intervention targets selective contributors to racial
disparities in pain
Barriers Element of Intervention
that targets barrier
Healthcare system barriers
associated with access and
utilization
Addressed by proactive telephone
outreach
Barriers associated with provider
communication
MI approaches used by counselors
Environmental barriers to exercise Action planning and MI approaches;
Coping, Supportive/facilitative, and
collaborative planning
Psychological Barriers (including
self-efficacy)
Action planning and MI
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(associated with delay of healthcare and unmet medical
needs), which will be assessed using the Perceived Dis-
crimination in Healthcare Scale [55], and the experi-
ences with VA care, assessed by the Evaluation of VA
Care scale, which is an 8-item scale measuring patient
satisfaction with and perceptions of quality of VA
healthcare [56]. We will also include 2 questions to as-
sess general utilization of pain treatment in the past
6 months. At 3-months and 6-months, we will include a
single item measure assessing how patients rate their
quality of pain care at the VA in the past 6 months.
Pain treatment In order to further assess use of opioid
analgesics, we will obtain prescription information from
electronic medical records. We will include survey ques-
tions to assess the use of opioids and non-opioid treatments
for pain.
Table 2 Outcomes measures
Construct Measure 0 mo 3 mo 6 mo
Baseline screening questions
Race/ethnicity Standard measures of race and ethnicity X
Pain intensity/interference Brief pain intensity and interference scale (PEG) X
Ability to walk a block Single-item screening question X
Cognitive screener Callahan Measure X
Anticipated back, knee or hip or other major
surgery in next 12 mo.
Single-item question X
Primary Chronic Pain Outcome
Disease-specific functioning Revised Roland and Morris Disability Questionnaire (RMD) X X X
Secondary Chronic Pain Outcomes
Pain intensity/interference Brief pain intensity and interference scale (PEG) X X X
Emotional functioning Personal Health Questionnaire Depression Scale (PHQ-8) X X X
Emotional functioning Generalized Anxiety Disorder 7 item (GAD-7) X X X
Overall improvement Patient Global Impression of Change scale X X
Walking (mediator)
Average daily total steps Pedometer data recorded over past 7 days on patient logs X X X
Utilization of pain treatment
Use of opioid analgesics Prescription records from Electronic Medical Records X X X
Use of opioid analgesics Survey items X X X
Perceived satisfaction with pain care Single item assessing how patients rate their quality of pain
care in VA over past 6 months
X X
Psychological factors (mediators)
Exercise self-efficacy Exercise Regularly Scale X X X
Pain management self-efficacy Pain Self-Efficacy Questionnaire-8 item version (PSEQ-8). X X X
Pain-related fear avoidance Fear-Avoidance Beliefs Questionnaire (FABQ) Scale 1: Fear-avoidance
beliefs about physical activity
X X X
Environmental factors
Social support Social Support for Exercise: Marcus Social Support Questions X
Relationship Stress Life Stressors Inventory (LISRES-A) X
Neighborhood walkability Neighborhood Environment Walkability Scale (NEWS) X
Healthcare Utilization and Provider Factors
Experiences of discrimination Perceived Discrimination in Healthcare X
Mistrust of medical care Evaluation of VA Care scale X
Sociodemographic and health-related factors
Sociodemographic factors Standard measures of education, income, employment status,
disability status
X
Health-related factors BMI, use of walking aid, claim status, X
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Sociodemographic and health-related factors Partici-
pants will be asked to provide information about whether
they use a walking aid and information (i.e., height and
weight) used to calculate their Body Mass Index. We also
will assess basic socio-demographic information such as
education level, income, employment status, and disability
status (e.g., worker’s compensation, Social Security
Disability Insurance, VA service connection).
Analysis plan
Power and sample size estimate
Our sample size calculation uses the RMD score as the
primary outcome at six months. For our primary analysis
we will use a responder analysis, in which we define clinic-
ally significant changes as a 30% reduction in pain disabil-
ity from baseline, using the RMD, and have powered the
study to be able to detect this change. This is the accepted
threshold for clinically significant improvement in clin-
ical trials and recommended by the IMMPACT guide-
lines [57, 58]. Previous studies demonstrate that a 30%
reduction on the RMD is a clinically important differ-
ence [59, 60]. Prior studies have shown that 15-20% of
UC patients demonstrate a 30% reduction in pain func-
tion score (using the RMD and similar measures) from
baseline to follow-up [61, 62]. Thus, in order to detect
an absolute difference of 20% in the primary outcome
measure between treatment groups (i.e.15-20% responders
in the UC group compared with at least 35-40% re-
sponders in the intervention group), we estimate that we
need between 86 and 97 people in each group with
complete data. This estimate takes into account that we
set the alpha error rate to look at African American and
non-African American patients separately [63, 64].
We factored in that up to 50% of the study sample
might be non-African American. Since we want to have
power to detect meaningful effects in the subgroup that
only includes African American patients (~100/50% =
200), and to allow for up to 20% attrition, we will need
to randomize 250 patients for each arm of the study, for
a total of 500 patients recruited with at least 200 African
American patients with complete data for the final ana-
lyses. For the purposes of this study, we are not forcing
balance between African American and non-African
American participants, and are instead allowing for the
potential that more than half of the participants are
African American, since assessing efficacy of the inter-
vention in a population of African American pain pa-
tients is the primary target.
Primary aims
The primary aims are to test the hypothesis that the
intervention will improve chronic pain-specific physical
functioning—the primary outcome (H1a), improve emo-
tional functioning, pain severity and ratings of overall
improvement (H1b), and increase walking (H1c), com-
pared to UC for African American patients with chronic
hip, back, and knee pain.
After assessing data for normality and evidence of bal-
ance of baseline factors across intervention groups, gener-
alized linear regression models will be used to estimate
the main effects of the intervention for all participants
(African Americans and non-African Americans).
To compare the effects of the intervention to UC on
the IMMPACT measures of pain outcomes, the primary
outcome measure is the RMD score assessed at 6 months
(i.e. primarily a 30% reduction from baseline and second-
arily mean change from baseline) (aim 1a). The secondary
outcome measures are pain severity, the PHQ-8 and
GAD-7, and the global rating of change scale (aim 1b).
For all of these outcomes we will use generalized linear
regression fit using appropriate distribution and link func-
tions. Each participant will be modeled as a random inter-
cept to allow within-patient correlation of the repeated
measures. The use of a mixed-effects model will allow us
to use data from participants who may be missing either
baseline or the 6-month data while giving an unbiased
estimate of the outcome comparisons as long as missing
data is approximately random.
To compare the effects of the intervention to UC on
increasing walking behavior (aim 1c), walking will be
measured by step counts, which are reported based on
readings from the Omron HJ-321 pedometer. The ef-
fect of the intervention on step counts will be assessed
by comparing average daily step counts measured over
7 days. We will use a mixed-effects model with the
average daily step counts during the last week of the
three month and six month measurement points as the
dependent variables, with a similar analytic plan as de-
scribed for Aim 1a.
Secondary aims
Our secondary aim is to investigate whether key contrib-
utors to racial/ethnic disparities targeted by the inter-
vention (motivation to exercise, pain/exercise efficacy,
reduction of pain-related fear, increased physical activity)
mediate improvement in chronic pain outcomes.
The key measures for this aim include the Fear-
Avoidance Beliefs Questionnaire (FABQ) [51], the
Exercise Regularly Scale [43], the Pain Self-Efficacy
Questionnaire (PSEQ), and average daily step counts
measured over 7 days [44]. Each of these will be mea-
sured at baseline, three and six month, and each has
continuous distributions, and therefore, analytic ap-
proaches for each of these measures will be identical to
that of Primary Aim 1 with the primary objective of
assessing the long-term (6 month) effect of the inter-
vention on these outcomes and secondary objective of
exploring outcome trends over time. Indirect effects
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will be directly tested using the bootstrap approach to
obtaining confidence intervals [65] to avoid the often-
violated assumption underlying Sobel’s (1982) method
that the sampling distribution of the indirect effect be
normal [66].
Our secondary aim 2 is to explore whether the inter-
vention reduces use of opioid analgesics. Using similar
analytical methods as described for the Primary Aims,
we will use generalized linear models to explore whether
use of opioid analgesics are reduced in the intervention
group compared to the UC group, using survey re-
sponses and pharmacy data. We will compare the pro-
portion of participants who, at baseline, report taking
opioids at baseline at the 6-month follow-up report that
they no longer take opioids, using the question, “Do you
take an opioid medication for pain? (Examples: codeine,
Tylenol #3, hydrocodone, Vicodin®, hydromorphone,
methadone, morphine, oxycodone, Percocet®, etc.).” We
will also examine opioid daily dose reduction of 50%
from baseline to 6 months, based on VA pharmacy dis-
pensing data that has been converted to morphine
equivalent doses.
Our secondary aim 3 is to determine if the interven-
tion is effective for non-African American VA patients
and other subgroups of patients who may experience
barriers to effective pain treatment. We will also explore
whether there are differences in effectiveness between
African American and non-African American patients.
We will conduct the same analyses as for the Primary
Aims and Secondary Aims 1–2 on the sample of non-
African American patients (most of whom are expected
to be white) and subgroups based on key demographic
factors (age, gender, education and income) and psycho-
logical, environmental and utilization factors, measured
at the baseline survey that we included because they are
expected to constitute barriers to effective pain treat-
ment, based on our theoretical framework. We will also
explore whether treatment effects will be moderated by
common psychiatric conditions (anxiety and depression)
and receipt of other forms of pain treatment.
Limitations
UC patients will receive some intervention elements (e.g.,
they will receive a pedometer and some of the educational
content). Nevertheless, we believe that the design repre-
sents the optimal compromise between scientific rigor
and real-world practicality. Further, we expect that neither
the pedometer nor the extra education will have a sub-
stantial influence on our primary outcome. If they do have
any impact, the effect would be to reduce the likelihood of
finding treatment differences between the control and
intervention groups. Thus, the design for this study will
provide rigorous evidence about the effectiveness of the
proposed intervention.
Another limitation inherent to this design is that, if
the program is effective, we will not be able to determine
the specific intervention element responsible for the
success of the program. We decided to test a multi-
component intervention, rather than test different com-
ponents of the intervention separately, in order to target
key factors that we believe are necessary to increase
walking in this population, and to ensure that the inter-
vention was potent enough to affect change.
Discussion
Presently, there is evidence of racial disparities in pain
and pain treatment in the US but few interventions
designed to specifically work well in populations most
impacted by these disparities. This project adds to the
evidence base on how to best improve pain treatment
for African American patients with musculoskeletal pain,
as well as other individuals who experience similar con-
tributors to pain, and on the specific mechanisms that
contribute to this reduction.
One innovative aspect of this study is that it uses pro-
active telephone outreach to increase physical activity
among patients with musculoskeletal pain. In proactive
telephone outreach, counselors reach out to patients,
offering them treatment, as compared to “reactive
care,” in which the individual patient must initiate
treatment. Proactive outreach can address barriers that
members of negatively stereotyped groups (such as mi-
nority patients and chronic pain patients) are likely to
experience. For example, such patients may experience
poor quality communication with providers, and dis-
crimination within and outside the healthcare system,
which is associated with avoiding and delaying health-
care (i.e., barriers to healthcare utilization) [1–3, 5–15,
32]. Our proposed intervention also applies action
planning, which has been shown to increase the likeli-
hood of behavioral change, to promote physical activity
in patients with musculoskeletal pain, and is the only
one that specifically focuses on minority pain patients.
Action planning, which has been shown to be particu-
larly effective for situations in which self-regulatory
capacity is diminished [67], is likely to be helpful for
African Americans, who experience many situations that
diminish regulatory capacity, such as social exclusion, ra-
cial discrimination, and stereotype threat [67, 68]. Action
Planning is also likely to be helpful for patients with pain,
as pain diminishes self-regulatory capacity [69].
At the present time when we are in the midst of a
public health crisis caused by increased prescription of
opioids [70], with limited evidence about the lack of long
term effectiveness for its use in treating of chronic mus-
culoskeletal pain [71–73], it is particularly important
that effective, nonpharmacological approaches to pain
management be developed, and made widely available.
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Through a proactive outreach approach to delivering a
nonpharmacological intervention, the present study has
the promise of increasing both equity and quality of
treatment for chronic musculoskeletal pain.
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